Business Description
Nuvectis Pharma is a New Jersey-based drug development company founded in 2020 and focused on creating targeted cancer treatments. Its lead program, NXP900, is currently in early-stage human trials and works by blocking specific proteins that drive tumor growth. The company aims to address cancers where patients currently have few effective treatment options.
